Suppr超能文献

奈替米星在肾功能损害患者及透析患者中的药代动力学。

Pharmacokinetics of netilmicin in patients with renal impairment and in patients on dialysis.

作者信息

Luft F C, Brannon D R, Stropes L L, Costello R J, Sloan R S, Maxwell D R

出版信息

Antimicrob Agents Chemother. 1978 Sep;14(3):403-7. doi: 10.1128/AAC.14.3.403.

Abstract

The pharmacokinetics of netilmicin were examined in 25 adult subjects, 7 normal subjects, and 18 patients with renal impairment. Five were dialysis patients who were studied on and off dialysis. Netilmicin, 2 mg/kg, was infused intravenously over 1 h. The peak serum concentration ranged from 9 to 11 mug/ml. The mean biological half-life of netilmicin for subjects with a creatinine clearance (Ccr) > 70 ml/min was 2.7 h, for those with Ccr > 25 < 70 ml/min it was 10 h, for those with Ccr > 4 < 25 ml/min it was 32 h, and for those who were anephric it was 42 h. Ccr was correlated positively with the elimination constant and the drug's serum clearance. It was negatively correlated with the drug's volume of distribution. The dialyzer clearance of netilmicin was positively correlated with plasma flow rate and was similar to values previously reported for gentamicin. Netilmicin behaves in a fashion similar to other aminoglycosides. Therapeutic guidelines are suggested.

摘要

对25名成年受试者(7名正常受试者和18名肾功能不全患者)进行了奈替米星的药代动力学研究。其中5名是透析患者,分别在透析时和透析后进行了研究。以2mg/kg的剂量将奈替米星静脉输注1小时。血清峰值浓度在9至11μg/ml之间。肌酐清除率(Ccr)>70ml/min的受试者中,奈替米星的平均生物半衰期为2.7小时;Ccr>25<70ml/min的受试者中,其平均生物半衰期为10小时;Ccr>4<25ml/min的受试者中,其平均生物半衰期为32小时;无肾的受试者中,其平均生物半衰期为42小时。Ccr与消除常数及药物的血清清除率呈正相关。它与药物的分布容积呈负相关。奈替米星的透析器清除率与血浆流速呈正相关,与先前报道的庆大霉素的值相似。奈替米星的行为方式与其他氨基糖苷类药物相似。文中提出了治疗指南。

相似文献

4
Predicted tissue accumulation of netilmicin in patients.奈替米星在患者体内的预测组织蓄积情况。
Antimicrob Agents Chemother. 1981 Dec;20(6):714-7. doi: 10.1128/AAC.20.6.714.
5
Multicompartment pharmacokinetics of netilmicin.奈替米星的多房室药代动力学
Eur J Clin Pharmacol. 1979 Nov;16(5):331-4. doi: 10.1007/BF00605631.
10
Kinetics of netilmicin and gentamicin.奈替米星和庆大霉素的动力学
Clin Pharmacol Ther. 1978 May;23(5):591-7. doi: 10.1002/cpt1978235591.

引用本文的文献

4
Predicted tissue accumulation of netilmicin in patients.奈替米星在患者体内的预测组织蓄积情况。
Antimicrob Agents Chemother. 1981 Dec;20(6):714-7. doi: 10.1128/AAC.20.6.714.
7
Serum level monitoring of antibacterial drugs. A review.抗菌药物的血清水平监测。综述。
Clin Pharmacokinet. 1984 Nov-Dec;9(6):475-92. doi: 10.2165/00003088-198409060-00001.

本文引用的文献

2
[Renal excretion of gentamicin in man].[庆大霉素在人体中的肾脏排泄]
Dtsch Med Wochenschr. 1972 Oct 6;97(40):1496-8 passim. doi: 10.1055/s-0028-1107589.
4
Serum protein binding of the aminoglycoside antibiotics.氨基糖苷类抗生素的血清蛋白结合情况。
Antimicrob Agents Chemother. 1972 Sep;2(3):214-6. doi: 10.1128/AAC.2.3.214.
6
Comparative pharmacokinetics of tobramycin and gentamicin.妥布霉素和庆大霉素的比较药代动力学
Clin Pharmacol Ther. 1973 May-Jun;14(3):396-403. doi: 10.1002/cpt1973143396.
7
Tobramycin in renal impairment.肾功能损害时的妥布霉素
Am J Med Sci. 1975 May-Jun;269(3):317-21. doi: 10.1097/00000441-197505000-00004.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验